Your browser doesn't support javascript.
loading
The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers.
Parr, Alan; Hidalgo, Ismael J; Bode, Chris; Brown, William; Yazdanian, Mehran; Gonzalez, Mario A; Sagawa, Kazuko; Miller, Kevin; Jiang, Wenlei; Stippler, Erika S.
Afiliação
  • Parr A; GlaxoSmithKline Inc., Research Triangle Park, North Carolina, 27709, USA.
  • Hidalgo IJ; Absorption Systems LP, Exton, Pennsylvania, 19341-2556, USA.
  • Bode C; Absorption Systems LP, Exton, Pennsylvania, 19341-2556, USA. cbode@absorption.com.
  • Brown W; US Pharmacopeial Convention, Rockville, Maryland, 20852, USA.
  • Yazdanian M; Teva Branded Pharmaceuticals R&D Inc., West Chester, Pennsylvania, 19380, USA.
  • Gonzalez MA; P'Kinetics International, Inc., Pembroke Pines, Florida, 33027, USA.
  • Sagawa K; Pfizer Global Research and Development, Groton, Connecticut, 06340, USA.
  • Miller K; GlaxoSmithKline Inc., Research Triangle Park, North Carolina, 27709, USA.
  • Jiang W; Food and Drug Administration, Office of Generic Drugs, Silver Spring, Maryland, 20841, USA.
  • Stippler ES; US Pharmacopeial Convention, Rockville, Maryland, 20852, USA.
Pharm Res ; 33(1): 167-76, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26286187
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biofarmácia / Excipientes Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biofarmácia / Excipientes Idioma: En Ano de publicação: 2016 Tipo de documento: Article